APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer

The former CEO Dr. Hans Loibner will continue to support the Company as senior advisor.

Press release

Presseaussendung

 

Copyright © 2021 APEIRON Biologics AG. All rights reserved.